{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:39:30Z","timestamp":1762252770699},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004726","name":"Ministry of Health","doi-asserted-by":"publisher","award":["00023728"],"award-info":[{"award-number":["00023728"]}],"id":[{"id":"10.13039\/501100004726","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Institute of Rheumatology","award":["RVO VFN64165"],"award-info":[{"award-number":["RVO VFN64165"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.taap.2018.06.015","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T04:37:39Z","timestamp":1529469459000},"page":"102-108","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Thiopurine-induced toxicity is associated with dysfunction variant of the human molybdenum cofactor sulfurase gene (xanthinuria type II)"],"prefix":"10.1016","volume":"353","author":[{"given":"Blanka","family":"Stiburkova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerina","family":"Pavelcova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenka","family":"Petru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Krijt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2018.06.015_bb0005","first-page":"55","article-title":"MOSC domains: ancient, predicted sulfur-carrier domains, present in diverse metal-sulfur cluster biosynthesis proteins including molybdenum cofactor sulfurases","volume":"207","author":"Anantharaman","year":"2002","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.taap.2018.06.015_bb0010","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1046\/j.1365-2036.2002.01353.x","article-title":"Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease","volume":"16","author":"Ansari","year":"2002","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2018.06.015_bb0015","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/BF00866732","article-title":"Acute renal failure due to xanthine stones","volume":"9","author":"Bradbury","year":"1995","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.taap.2018.06.015_bb0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0140-6736(93)91287-V","article-title":"Low-dose allopurinol plus azathioprine\/cyclosporin\/prednisolone, a novel immunosuppressive regimen","volume":"342","author":"Chocair","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2018.06.015_bb0025","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1124\/dmd.114.058107","article-title":"In vitro oxidative metabolism of 6-mercaptopurine in human liver: insights into the role of the molybdoflavoenzymes aldehyde oxidase, xanthine oxidase, and xanthine dehydrogenase","volume":"42","author":"Choughule","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2018.06.015_bb0030","doi-asserted-by":"crossref","first-page":"34658","DOI":"10.1038\/srep34658","article-title":"Genes implicated in thiopurine-induced toxicity: comparing TPMT enzyme activity with clinical phenotype and exome data in a paediatric IBD cohort","volume":"6","author":"Coelho","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2018.06.015_bb0035","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10637-005-4020-8","article-title":"The thiopurines: an update","volume":"23","author":"Coulthard","year":"2005","journal-title":"Invest. New drugs"},{"key":"10.1016\/j.taap.2018.06.015_bb0040","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000357407","article-title":"Augmenting clinical interpretability of thiopurine methyltransferase laboratory evaluation","volume":"86","author":"Demlova","year":"2014","journal-title":"Oncology"},{"key":"10.1016\/j.taap.2018.06.015_bb0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ibd.21676","article-title":"Hypoxanthine guanine phosphoribosyltransferase activity is related to 6-thioguanine nucleotide concentrations and thiopurine-induced leukopenia in the treatment of inflammatory bowel disease","volume":"18","author":"Ding","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.taap.2018.06.015_bb0050","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/clpt.1991.205","article-title":"Human liver xanthine oxidase: nature and extent of individual variation","volume":"50","author":"Guerciolini","year":"1991","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2018.06.015_bb0055","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0378-1119(93)90652-J","article-title":"Cloning of the cDNA encoding human xanthine dehydrogenase (oxidase): structural analysis of the protein and chromosomal location of the gene","volume":"133","author":"Ichida","year":"1993","journal-title":"Gene"},{"key":"10.1016\/j.taap.2018.06.015_bb0060","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1006\/bbrc.2001.4719","article-title":"Mutation of human molybdenum cofactor sulfurase gene is responsible for classical xanthinuria type II","volume":"282","author":"Ichida","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.taap.2018.06.015_bb0065","doi-asserted-by":"crossref","first-page":"15475","DOI":"10.3390\/ijms131115475","article-title":"Mutations associated with functional disorder of xanthine oxidoreductase and hereditary xanthinuria in humans","volume":"21","author":"Ichida","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl. 3","key":"10.1016\/j.taap.2018.06.015_bb0070","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1007\/s10545-009-9011-z","article-title":"Xanthine dehydrogenase deficiency with novel sequence variations presenting as rheumatoid arthritis in a 78-year-old patient","volume":"33","author":"Jurecka","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.taap.2018.06.015_bb0075","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/ard.53.9.608","article-title":"Purine enzymes in rheumatoid arthritis: possible association with response to azathioprine, A pilot study","volume":"53","author":"Kerstens","year":"1994","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.taap.2018.06.015_bb0080","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev.biochem.66.1.233","article-title":"Molybdenum-cofactor-containing enzymes: structure and mechanism","volume":"66","author":"Kisker","year":"1997","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.taap.2018.06.015_bb0085","series-title":"TPMT but Not ITPA Gene Polymorphism Influences the Risk of Azathioprine Intolerance in Renal Transplant Recipients","author":"Kurzawski","year":"2009"},{"key":"10.1016\/j.taap.2018.06.015_bb0090","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/FTD.0b013e31824aa681","article-title":"Polymorphism of genes involved in purine metabolism (XDH, AOX1, MOCOS) in kidney transplant recipients receiving azathioprine","volume":"34","author":"Kurzawski","year":"2012","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.taap.2018.06.015_bb0095","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.bbamcr.2006.03.013","article-title":"Cell biology of molybdenum","volume":"1763","author":"Mendel","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2018.06.015_bb0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00240-014-0734-4","article-title":"Modern diagnostic approach to hereditary xanthinuria","volume":"43","author":"Mraz","year":"2015","journal-title":"Urolithiasis."},{"key":"10.1016\/j.taap.2018.06.015_bb0105","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1111\/j.1742-4658.2008.06489.x","article-title":"Mammalian xanthine oxidoreductase mechanism of transition from xanthine dehydrogenase to xanthine oxidase","volume":"275","author":"Nishino","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.taap.2018.06.015_bb0110","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0006-2952(90)90494-6","article-title":"Characterization of the DNA damage in 6-thioguanine-treated cells","volume":"40","author":"Pan","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2018.06.015_bb0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ymgme.2007.02.005","article-title":"Identification and characterization of the first mutation (Arg776Cys) in the C-terminal domain of the human molybdenum cofactor Sulfurase (HMCS) associated with type II classical xanthinuria","volume":"91","author":"Peretz","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.taap.2018.06.015_bb0120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cca.2016.06.007","article-title":"Genetic background of uric acid metabolism in a patient with severe chronic tophaceous gout","volume":"460","author":"Petru","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.taap.2018.06.015_bb0125","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2133\/dmpk.22.299","article-title":"In vitro study of 6-mercaptopurine oxidation catalysed by aldehyde oxidase and xanthine oxidase","volume":"22","author":"Rashidi","year":"2007","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.taap.2018.06.015_bb0130","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s004390050884","article-title":"Genomic structure and mutational spectrum of the bicistronic MOCS1 gene defective in molybdenum cofactor deficiency type a","volume":"103","author":"Reiss","year":"1998","journal-title":"Hum. Genet."},{"key":"10.1016\/j.taap.2018.06.015_bb0135","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/clpt.2010.320","article-title":"Clinical Pharmacogenetics implementation consortium, clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing","volume":"89","author":"Relling","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2018.06.015_bb0140","first-page":"987","article-title":"Hematotoxicity caused by azathioprine genetically determined and aggravated by xanthine oxidase deficiency in a patient following renal transplantation","volume":"24","author":"Serre-Debeauvais","year":"1995","journal-title":"Presse Med."},{"key":"10.1016\/j.taap.2018.06.015_bb0145","series-title":"Hereditary Xanthinuria","author":"Simmonds","year":"2003"},{"key":"10.1016\/j.taap.2018.06.015_bb0150","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2036.2009.04057.x","article-title":"Novel pharmacogenetic markers for treatment outcome in azathioprine-treated inflammatory bowel disease","volume":"30","author":"Smith","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2018.06.015_bb0155","first-page":"505","article-title":"Use of allopurinol to optimize thiopurine immunomodulator efficacy in inflammatory bowel disease","volume":"4","author":"Sparrow","year":"2008","journal-title":"Gastroenterol. Hepatol. (N Y)."},{"key":"10.1016\/j.taap.2018.06.015_bb0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cca.2011.08.038","article-title":"Novel mutations in xanthine dehydrogenase\/oxidase cause severe hypouricemia: biochemical and molecular genetic analysis in two Czech families with xanthinuria type I","volume":"413","author":"Stiburkova","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.taap.2018.06.015_bb0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/dna.1996.15.17","article-title":"Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism","volume":"15","author":"Szumlanski","year":"1996","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.taap.2018.06.015_bb0170","first-page":"694","article-title":"Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians","volume":"58","author":"Tai","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.taap.2018.06.015_bb0175","first-page":"651","article-title":"Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity","volume":"32","author":"Weinshilboum","year":"1980","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.taap.2018.06.015_bb0180","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/S0026-0495(03)00272-5","article-title":"Identification of a new point mutation in the human molybdenum cofactor sulferase gene that is responsible for xanthinuria type II","volume":"52","author":"Yamamoto","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.taap.2018.06.015_bb0185","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1159\/000374042","article-title":"Using next-generation sequencing to identify a mutation in human MCSU that is responsible for type II Xanthinuria","volume":"35","author":"Zhou","year":"2015","journal-title":"Cell. Physiol. Biochem."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18302813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18302813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T01:20:18Z","timestamp":1534814418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X18302813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":37,"alternative-id":["S0041008X18302813"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2018.06.015","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thiopurine-induced toxicity is associated with dysfunction variant of the human molybdenum cofactor sulfurase gene (xanthinuria type II)","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2018.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}